Add BrightSurf on Google Email

Search results for “Pathology”

1,000+ results for "Pathology"

St. Jude finds NLRP12 as a new drug target for infection, inflammation and hemolytic diseases

Researchers from St. Jude Children's Research Hospital discovered NLRP12 to be the key molecule responsible for inducing inflammatory cell death and pathology in response to heme combined with other cellular damage or infection. This finding provides a new potential drug target to prevent morbidity in certain illnesses.

SourceSt. Jude Children's Research Hospital·JournalCell·TypeExperimental study·DateJun 1, 2023

Tracking early signs of Alzheimer’s pathology in a mouse model

A new study in a mouse model of Alzheimer's disease examines the effects of environmental enrichment on AD symptom progression and pathology. The researchers found that living in an enriched environment improved several measures of metabolism and reduced individual behaviors, which became more similar and rigid as the disease progressed.

SourceElsevier·JournalBiological Psychiatry·TypeExperimental study·DateMay 31, 2023

New UCI-led research shows people who live to be 90+ with superior thinking skills are resilient to Alzheimer’s pathology in their brains

A UCI-led study reveals that the oldest-old, those living up to 90 years old, exhibit similar levels of brain pathology as Alzheimer's patients but with lower levels of pathology from other neurodegenerative diseases. This finding suggests these individuals may be resistant to these age-related cognitive decline.

SourceUniversity of California - Irvine·JournalJournal of Alzheimer’s Disease·DateMay 24, 2023

AMP offers evidence-based recommendations for next-generation sequencing germline variant confirmation

The Association for Molecular Pathology (AMP) has published a report establishing evidence-based recommendations for orthogonal confirmation practices of germline variants detected by next-generation sequencing. The guidelines aim to promote standardization, transparency, and quality improvement among laboratories.

SourceAssociation for Molecular Pathology·JournalJournal of Molecular Diagnostics·DateMay 18, 2023

Mass General Brigham researchers uncover metabolic secrets of anaerobes and identify new strategies to treat c. difficile infections

The study found that Clostridioides difficile uses fermentation to rapidly colonize the gut and identified critical pathways converged on a metabolic integration point to produce amino acid alanine, driving bacterial growth. The findings provide new targets for small molecule drugs to counter C. difficile colonization and infection.

SourceMass General Brigham·JournalNature Chemical Biology·TypeObservational study·DateMar 9, 2023

Artificial intelligence tool developed to help make real-time diagnoses during surgery

A new AI tool developed by Brigham and Women's Hospital improves the accuracy of time-critical pathology diagnostics during surgery. The tool, which leverages deep-learning technology, translates frozen tissue samples into high-quality images, increasing diagnostic accuracy and reducing the need for lengthy laboratory tests.

SourceBrigham and Women's Hospital·JournalNature Biomedical Engineering·TypeObservational study·DateDec 23, 2022

AMP assesses clinical implementation of past standards and guidelines for interpretation and reporting of sequence variants in cancer

The Association for Molecular Pathology (AMP) published a report assessing the clinical adoption, classification inconsistencies, and implementation barriers of the 2017 guidelines for sequence variant interpretation and reporting in cancer. The study found that 86% of participants correctly differentiated clinically significant varian...

SourceAssociation for Molecular Pathology·JournalJournal of Molecular Diagnostics·DateDec 13, 2022

Brain changes in autism are far more sweeping than previously known, UCLA-led study finds

A new UCLA-led study found comprehensive brain-wide changes in individuals with autism spectrum disorder, refining scientists' understanding of how the condition progresses. The study analyzed gene expression across 11 cortical regions, revealing strong evidence that RNA changes in the brain are likely the cause of ASD.

Association for molecular pathology offers recommendations for in silico approaches for validating next-generation sequencing analysis pipelines

The Association for Molecular Pathology (AMP) has published consensus recommendations for using in silico approaches to validate Next-Generation Sequencing (NGS) data analysis pipelines. The guidelines provide expert opinion on the advantages and disadvantages of different types of in silico data and offer general recommendations for s...

SourceAssociation for Molecular Pathology·JournalJournal of Molecular Diagnostics·DateOct 18, 2022

Mouse study explores Alzheimer’s link to the X chromosome

A mouse study found that female brains express higher levels of an X-linked enzyme called USP11, leading to greater accumulation of tau protein and increased vulnerability to Alzheimer's disease. The results suggest that excessive activity of USP11 drives this increased susceptibility in females.

SourceCell Press·JournalCell·TypeExperimental study·DateOct 4, 2022

Regulation is the name of the game

A new study by Kyoto University found that Regnase-1 gene expression is low in patients with pulmonary arterial hypertension (PAH), mirroring the pathology of humans. The protein's mRNA degradation leads to PAH inhibition, offering a potential new treatment for heart failure and premature death.

SourceKyoto University·JournalCirculation·TypeExperimental study·DateSep 6, 2022

AMP recommends minimum set of pharmacogenetic alleles to guide design, development, and validation of clinical TPMT and NUDT15 genotyping assays

The Association for Molecular Pathology has published consensus recommendations for clinical TPMT and NUDT15 genotyping assays, promoting standardization across laboratories. The report identifies a minimum set of alleles to include in clinical tests, enabling healthcare professionals to provide high-quality patient care.

SourceAssociation for Molecular Pathology·JournalJournal of Molecular Diagnostics·DateAug 25, 2022

Effects of lead poisoning may be reversible with early-childhood enrichment

New research from Thomas Jefferson University shows that early childhood enrichment can reverse the effects of lead poisoning on brain development. Over 3,500 genes in the hippocampus are affected by lead exposure, but approximately 80% of gene expression changes are reversed in animals living in stimulating environments.

SourceThomas Jefferson University·JournalScientific Reports·TypeExperimental study·DateJul 25, 2022

Simple skin biopsy can assess tissue damage related to COVID-19

Researchers found clots in small venous and arterial blood vessels in normal-looking skin from patients with severe COVID-19, distinguishable from other forms of respiratory illness. Antiviral proteins and interferon-induced inflammatory proteins were also detected, associated with disease severity.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateJul 14, 2022

BU researchers develop a novel AI algorithm for digital pathology analysis

Researchers at Boston University School of Medicine have developed a novel AI algorithm, Graph Transformer (GTP), to classify lung cancer subtypes based on whole slide images. The framework outperforms current state-of-the-art methods and has implications beyond digital pathology for computer vision applications.

SourceBoston University School of Medicine·JournalIEEE Transactions on Medical Imaging·TypeComputational simulation/modeling·DateMay 23, 2022

Elaine S. Jaffe, MD, to receive Inaugural AACR James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research

Dr. Elaine S. Jaffe is being recognized for her pioneering work in hematopathology, including the discovery of novel pathological entities and her development of standardized diagnostic criteria for lymphoma and leukemia. She has also made significant contributions to advancing cancer research, diagnosis, treatment, and prevention.

Association for Molecular Pathology and The American Society for Investigative Pathology announce new editor-in-chief for The Journal of Molecular Diagnostics

Ronald M. Przygodzki, MD, has been appointed as the new Editor-in-Chief of The Journal of Molecular Diagnostics, succeeding Barbara Zehnbauer, PhD. Dr. Przygodzki brings extensive experience in genomic medicine and molecular diagnostics to the position.

SourceAssociation for Molecular Pathology·JournalJournal of Molecular Diagnostics·DateFeb 9, 2022

First U.S. peer-reviewed study on omicron patient outcomes reveals rapid spread and significant differences in infection behavior

The first US peer-reviewed study on omicron patient outcomes found significant differences in infection behavior. Ominron patients are significantly younger, have increased vaccine breakthrough rates, and are less likely to be hospitalized compared to patients with alpha or delta variants.

SourceHouston Methodist·JournalAmerican Journal Of Pathology·TypeData/statistical analysis·DateFeb 3, 2022

Findings open the way to more precise diagnoses and treatments of Alzheimer’s disease

A research team led by Case Western Reserve University has discovered a link between misshapen tau protein and accelerated cognitive decline in Alzheimer's disease, potentially leading to more accurate prognoses. The study found distinct populations of highly potent TAU seed conformers in rapidly progressing cases.

SourceCase Western Reserve University·JournalScience Translational Medicine·TypeImaging analysis·DateJan 5, 2022

Breast cancer classified into 12 unique biological groups

Researchers at UNC Lineberger Comprehensive Cancer Center have developed a novel way to classify breast cancers into 12 distinct biological groups using both genetic and pathologic data. This classification method has the potential to aid future research efforts and enable faster translation of molecular findings into clinical use.

SourceUNC Lineberger Comprehensive Cancer Center·JournalCell Genomics·TypeData/statistical analysis·DateDec 8, 2021

Association for Molecular Pathology leaders publish recommendations to improve diagnostic testing response for current COVID-19 pandemic and future emerging outbreaks

The Association for Molecular Pathology (AMP) has published new guidelines to improve the US' ability to respond to emerging infectious disease outbreaks. The recommendations focus on better collaboration between public health, clinical laboratories, and government agencies.

SourceAssociation for Molecular Pathology·JournalJAMA Health Forum·DateNov 1, 2021